On the recordNovember 18, 2015
Part of the problem is it is a market-based technology?
Source
congress.govPart of the problem is it is a market-based technology?
DeGette questions the market dynamics affecting the adoption of new vaccine technologies.
Share
More from Diana DeGette
the minority intends to make sure that there is no waste, fraud, or abuse in these programs
It is a little embarrassing for someone like me, who is trying to tell colleagues around the world that we need to have robust oversight, that the U.S. Congress is actually having an oversight hearing that is so vague that you can't…
I would suggest, Madam Chair, that we actually have hearings directed at specific programs.